NDLI: Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium

Please wait, while we are loading the content...

Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shape

Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium

Fate of single walled carbon nanotubes in wetland ecosystems

Capabilities of asymmetric flow field-flow fractionation coupled to multi-angle light scattering to detect carbon nanotubes in soot and soil

Towards elucidating the effects of purified MWCNTs on human lung epithelial cells

Back cover

Environmental Science: Nano Vol - 1 Issue - 5

Environmental Science: Nano Vol - 1 Issue - 4

Environmental Science: Nano Vol - 1 Issue - 3

Environmental Science: Nano Vol - 1 Issue - 2

Environmental Science: Nano Vol - 1 Issue - 1

Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium

Content Provider	Royal Society of Chemistry (RSC)
Author	Jimenez, Renato J. Demokritou, Philip Brain, Joseph D. Wohlleben, Wendel Konduru, Nagarjun V. Molina, Ramon M. Pyrgiotakis, Georgios
Copyright Year	2014
Abstract	Cerium oxide nanoparticles (NPs) have wide commercial applications. Understanding their fate in the body is fundamental to toxicological evaluations. We compared bioavailability, tissue distribution, clearance and excretion of radioactive 141Ce after intratracheal instillation (IT), gavage, or intravenous (IV) injection of neutron-activated 141CeO2 NPs and 141CeCl3 (ionic 141Ce) in Wistar Han rats. First, we evaluated pulmonary responses to IT-instilled CeO2 NPs and CeCl3 and observed dose-dependent inflammatory effects. Then, groups of rats were IT-instilled with 1 mg kg−1 of 141CeO2 NPs or 0.1 mg kg−1 141CeCl3. Sequential analyses of lungs over 28 days showed slow lung clearance of 141CeO2 NPs (half-life = ~140 days) and of ionic 141Ce (half-life = ~55 days). However, less than 1% and 6% of instilled 141Ce was measured in selected extrapulmonary organs in 141CeO2 NPs and ionic 141Ce groups, respectively. Following gavage (5 mg kg−1), nearly 100% of both test materials was excreted in the feces. Since detected 141Ce activity in tissues could be in nanoparticulate or dissolved form, we also compared the 141Ce tissue distribution post-IV injection with the IT and gavage data. Both IV-injected ionic 141CeCl3 and 141CeO2 NPs were predominantly retained in the liver, bone and spleen, all organs that typically remove circulating particles. We conclude that nanoceria is slowly cleared from the lungs but has minimal extrapulmonary accumulation. Potential risks from prolonged pulmonary retention need further investigation. Risk from ingested nanoceria is likely far lower due to very low absorption and rapid elimination of ceria not absorbed from the gastrointestinal tract.
Starting Page	561
Ending Page	573
Page Count	13
File Format	HTM / HTML PDF
ISSN	20518153
Volume Number	1
Issue Number	6
Journal	Environmental Science: Nano
DOI	10.1039/c4en00034j
Language	English
Publisher	Royal Society of Chemistry
Access Restriction	Open
Subject Keyword	Cerium(IV) oxide Bioavailability Radioactive decay Intratracheal instillation Force-feeding Lung Biological half-life Liver Bone Spleen Gastrointestinal tract
Content Type	Text
Resource Type	Article
Subject	Environmental Science Materials Science

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles

Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles

The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice

The impact of instilled carbide nanoparticles on rat lungs: anin vivoperspective on acute intratracheal instillation

Induction of Inflammatory Responses in Mice Treated with Cerium Oxide Nanoparticles by Intratracheal Instillation

Evaluation of the effect of valence state on cerium oxide nanoparticle toxicity following intratracheal instillation in rats

Evaluation of Pulmonary Toxicity of Zinc Oxide Nanoparticles Following Inhalation and Intratracheal Instillation

Pulmonary toxicity of well-dispersed cerium oxide nanoparticles following intratracheal instillation and inhalation.

Histopathological and immunological changes induced by magnetite nanoparticles in the spleen, liver and genital tract of mice following intravaginal instillation

Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium

Similar Documents

Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles

Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles

The acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in mice

The impact of instilled carbide nanoparticles on rat lungs: anin vivoperspective on acute intratracheal instillation

Induction of Inflammatory Responses in Mice Treated with Cerium Oxide Nanoparticles by Intratracheal Instillation

Evaluation of the effect of valence state on cerium oxide nanoparticle toxicity following intratracheal instillation in rats

Evaluation of Pulmonary Toxicity of Zinc Oxide Nanoparticles Following Inhalation and Intratracheal Instillation

Pulmonary toxicity of well-dispersed cerium oxide nanoparticles following intratracheal instillation and inhalation.

Histopathological and immunological changes induced by magnetite nanoparticles in the spleen, liver and genital tract of mice following intravaginal instillation

Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium